Medicinal cannabis was legalised in Australia in November 2016. The global legal cannabis market is expected to grow to over US$20 billion by 2020.
Come and learn about the latest trends and scientific research in this exciting new field from a range of experts.
DATE AND TIME:
Wednesday 17 May 2017
7pm - 9pm
Centenary 118 Lecture Theatre
University of Tasmania
Churchill Avenue, Hobart
Paul Mavor - Health House International
Paul is a pharmacist who has been researching the potential of medicinal cannabis as a treatment for several years. His company was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Paul brings a wealth of knowledge from his hands-on research in the U.S., Canada and Israel.
Dr David Basser - Dentist
David’s clinical and academic foundation is specialist level dentistry, with extensive experience in pain management. He will discuss clinical applications of cannabis for chronic pain.
Ian Magill - Pharmacist
Ian Magill graduated from the University of Queensland in pharmacy in 1997. Since then he has worked in a hospital pharmacy and community pharmacies in Queensland and Victoria. In 2008, he moved to Tasmania, purchasing a pharmacy in the rural township of Geeveston, in the Huon Valley. Within this environment, he has seen firsthand the positive effects of medicinal cannabis on his patients. From children with epilepsy, to elderly people with Parkinson’s Disease, and others living with chronic pain. As a result, he has become a strong supporter for the legalisation of medicinal cannabis; a drug that causes less harm than many of the drugs he dispenses each day for chronic pain. Ian has advocated at the highest level of government in Tasmania for changes in the law nationally and within the state, which would enable the growing, manufacturing and prescribing of medicinal cannabis products.
Rhys is a political economist, industry expert and educator. Since leading the team behind the first Australian medicinal cannabis industry White Paper, he has consulted on a variety of commercial projects and is now the Program Director at Cann10 Australia which will be running the country’s first comprehensive medicinal cannabis education program later this year. Rhys will be discussing the emergence of the Australian industry as well as current global trends in legal cannabis markets.
- Seminar may qualify for Continuing Education (CE/CPD) points and includes an optional 5 question multiple choice test.